Laurus Labs joins hands with Unitaid, CHAI to develop and commercialise pediatric HIV drug combo Laurus will be provided with a financial incentive for a portion of their development and commercialisation costs. CHAI will work closely with Laurus Labs to provide technical and regulatory support to enable accelerated generic development and regulatory submission of the medication.